![]() ![]() We’re delighted that this market consolidation will enable further improvements to the excellent service that Phlo offers to patients and partners, and also allow us to extend that service by welcoming new patients and partners across the country. Nadeem Sarwar, Founder and CEO of Phlo, comments: “Phlo’s acquisition of Truepill UK marks a hugely significant moment in the evolution of digital healthcare in the UK. Phlo plans to increase its headcount, which is now at 90 employees across the UK, and all of Truepill UK’s existing pharmacy and warehouse staff have been offered jobs with Phlo. Phlo Digital Pharmacy is the challenger brand owned by Phlo Technologies which provides patients with a seamless end-to-end NHS digital pharmacy service to patients across England. Phlo Digital Pharmacy has also acquired Truepill’s NHS patient base. This consolidation will enable Phlo to expand the geographic footprint of its operations, with plans including the launch of same-day on-demand medication delivery in Manchester alongside existing services in Birmingham and London. Enhancing and expanding digital pharmacy services Both organisations have also agreed to explore further joint ventures as appropriate. Once integrated, Phlo’s technology will facilitate the prescribing, dispensing and delivery of prescribed and off-the-shelf medications and treatments directly to the users of these platforms.Īs part of a commercial partnership attached to the deal, Phlo has committed to supporting Truepill’s US partners should any of them look to launch into the UK market. Phlo has also acquired Truepill UK’s technology stack including their full set of Application Programming Interfaces (APIs) and prescribing technology. Veri, an individualised metabolic health platform.Hanx, stigma-free contraception and intimate care pioneers.Daye, a London-founded gynaecological health platform.Levels, a metabolic-health-focused software company.The Lowdown, a contraceptive advice and support platform.Phlo has acquired Truepill’s partnerships with several of the UK’s most popular digital healthcare providers, including: Phlo emerged as the preferred bidder on account of synergies in technology infrastructure, patient care, and the pharmacy services provided both for NHS and private partners. A strategic consolidationįollowing Truepill’s decision to focus solely on its US operations, a highly competitive bidding process for the acquisition of the UK business was announced in the autumn of 2022. This acquisition follows Phlo’s £10m Series A raise, announced in February 2023. This is a landmark consolidation in the sector, and one of the most significant acquisition deals in the history of digital pharmacy in the UK. The micro-encapsulation of the actives in tiny, biologically-active nano-particles (invisible to the eye) creates protective "coats" allowing immediate, rapid absorption (beginning through the membranes of the mouth) and protection of the payloads through the hostile environment of the stomach.ĪQUIS also contains the Company's VEP/PPC technology, which involves the effective delivery to the bloodstream of payloads that repair and protect cellular mechanisms which maintain vigorous longevity.Phlo Technologies, the UK digital pharmacy, have today announced its acquisition of the UK arm of US-based healthcare unicorn Truepill. The MEDS technology involves encapsulation of the payloads for fast and efficient delivery into the bloodstream. Cell Repair - Everyone Needs a Second Chance.ĪQUIS rehydration products deliver electrolyte payloads through the Company's MEDS, which enables actives to cross cellular membranes and rapidly distribute to target tissue. The Company plans to produce additional product to meet launch requirements of other distributors in January.ĪQUIS contains the Company's Micro-Encapsulation Delivery System and VEP/PPC which features a cell repair payload. AQUIS has been given favorable placement on the top shelf of cold boxes and on end-caps in high end, prominent grocery stores in those areas. Initial shipments have been primarily to accounts in the Santa Cruz/Monterey Bay, California areas, where the product is gaining significant traction. AQUIS rehydration products deliver electrolyte payloads through the Company's MEDS, which enables actives to cross cellular membranes and rapidly distribute to target tissue.ġ5/12/06 Phlo Corporation announced that one of its affiliates has commenced shipments of the ready-to-drink version of its rehydration/athletic life beverage, AQUIS Rapid Response Rehydration, to fill initial orders of the product. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |